Back
CytoDyn, Inc. 10K Form
Sell
30
CYDY
CytoDyn, Inc.
Last Price:
$0.25
Seasonality Move:
8.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-10-09 | 10Q | CYDY/CytoDyn, Inc. Quarterly |
| 2020-08-14 | 10K | CYDY/CytoDyn, Inc. Annual |
| 2020-04-09 | 10Q | CYDY/CytoDyn, Inc. Quarterly |
| 2020-01-09 | 10Q | CYDY/CytoDyn, Inc. Quarterly |
| 2019-10-08 | 10Q | CYDY/CytoDyn, Inc. Quarterly |
| 2019-08-14 | 10K | CYDY/CytoDyn, Inc. Annual |
Receive CYDY News And Ratings
See the #1 stock for the next 7 days that we like better than CYDY
CYDY Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.09 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.03220 |
|---|---|
| Net Income (TTM): | $-38.9M |
| Gross Margin: | $-18K |
| Return on Equity: | 0% |
| Return on Assets: | -224.54% |
CytoDyn, Inc. Earnings Forecast
Key CytoDyn, Inc. Financial Ratios
-
The Interest Expense is 129.67% of Operating Income.
-
Per Share Earnings over the last 23 years have been positive in 9 years.
CytoDyn, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CYDY |
| Website: | cytodyn.com |
Debt
| Debt-to-Equity Ratio: | -0.23 |
|---|---|
| Current Ratio: | 0.1 |
| Quick Ratio: | 0.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 135.75 |
|---|---|
| Forward P/E Ratio: | 0 |
CYDY Technical Analysis vs Fundamental Analysis
Sell
30
CytoDyn, Inc. (CYDY)
is a Sell
Is CytoDyn, Inc. a Buy or a Sell?
-
CytoDyn, Inc. stock is rated a SellThe current CytoDyn, Inc. [CYDY] share price is $0.24. The Score for CYDY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.